Cargando…
Incidence, clinical presentation, risk factors, outcomes, and biomarkers in de novo late acute GVHD
Late acute graft-versus-host disease (GVHD) is defined as de novo acute GVHD presenting beyond 100 days after allogeneic hematopoietic cell transplantation (HCT) without manifestations of chronic GVHD. Data are limited regarding its characteristics, clinical course, and risk factors because of under...
Autores principales: | Akahoshi, Yu, Spyrou, Nikolaos, Hogan, William J., Ayuk, Francis, DeFilipp, Zachariah, Weber, Daniela, Choe, Hannah K., Hexner, Elizabeth O., Rösler, Wolf, Etra, Aaron M., Sandhu, Karamjeet, Yanik, Gregory A., Chanswangphuwana, Chantiya, Kitko, Carrie L., Reshef, Ran, Kraus, Sabrina, Wölfl, Matthias, Eder, Matthias, Bertrand, Hannah, Qayed, Muna, Merli, Pietro, Grupp, Stephan A., Aguayo-Hiraldo, Paibel, Schechter, Tal, Ullrich, Evelyn, Baez, Janna, Beheshti, Rahnuma, Gleich, Sigrun, Kowalyk, Steven, Morales, George, Young, Rachel, Kwon, Deukwoo, Nakamura, Ryotaro, Levine, John E., Ferrara, James L. M., Chen, Yi-Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Hematology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10440469/ https://www.ncbi.nlm.nih.gov/pubmed/37315175 http://dx.doi.org/10.1182/bloodadvances.2023009885 |
Ejemplares similares
-
The utility of biomarkers in acute GVHD prognostication
por: Spyrou, Nikolaos, et al.
Publicado: (2023) -
Phase 2 study of natalizumab plus standard corticosteroid treatment for high-risk acute graft-versus-host disease
por: Al Malki, Monzr M., et al.
Publicado: (2023) -
Assessment of systemic and gastrointestinal tissue damage biomarkers for GVHD risk stratification
por: Etra, Aaron, et al.
Publicado: (2022) -
Disease Risk and GVHD Biomarkers Can Stratify Patients For Risk of Relapse and Non-Relapse Mortality Post Hematopoietic Cell Transplant
por: Aziz, Mina D., et al.
Publicado: (2020) -
Clinical characteristics of oral chronic graft-versus-host disease according to the 2014 National Institutes of Health (USA) consensus criteria
por: Pengpis, Nawaporn, et al.
Publicado: (2023)